Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.291 USD | +1.89% | -13.00% | -79.06% |
03-19 | Wall Street Set to Open Lower Ahead of Two-Day Fed Meeting; Housing Starts Surge Higher Than Expected | MT |
03-19 | Seelos Therapeutics' ALS treatment fails in mid-stage study | RE |
Business Summary
Number of employees: 16
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical Products
100.0
%
| 0 | nan % | 2 | 100.0 % | - |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | nan % | 2 | 100.0 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Raj Mehra
CEO | Chief Executive Officer | 64 | 31/12/86 |
Director of Finance/CFO | 52 | 31/12/18 | |
Karen Fusaro
CTO | Chief Tech/Sci/R&D Officer | - | - |
Gopal Krishna
CTO | Chief Tech/Sci/R&D Officer | - | - |
Chief Tech/Sci/R&D Officer | 66 | - | |
Anthony Marciano
IRC | Investor Relations Contact | - | 31/07/17 |
Lucas Pilipski
PRN | Corporate Officer/Principal | - | 30/11/20 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 77 | 31/08/21 | |
Richard Pascoe
BRD | Director/Board Member | 60 | 28/02/13 |
Daniel O'Connor
BRD | Director/Board Member | 59 | 31/12/18 |
Brian Lian
BRD | Director/Board Member | 58 | 31/12/18 |
Raj Mehra
CEO | Chief Executive Officer | 64 | 31/12/86 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 13,680,576 | 13,406,690 ( 98.00 %) | 0 | 98.00 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
REGNUM CORP. 98.82% | 22,680,000 | 98.82% | 725,760 $ |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
-79.06% | 3.98M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- SEEL Stock
- Company Seelos Therapeutics, Inc.